转录因子激活增强剂结合蛋白2ε (AP2ε) 调节表型可塑性和恶性黑色素瘤的进展
Sebastian Staebler1, Ulrike Rottensteiner-Brandl1, Zubeir El Ahmad1,2
1Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Fahrstraße 17, 91054, Erlangen, Germany.
Cell death & disease
|May 21, 2024
概括
转录因子激活增强剂结合蛋白2ε (AP2ε) 驱动黑色素瘤转移和可塑性. 降低AP2ε会影响黑色素瘤细胞的迁移和扩散,突出其在侵袭性皮肤癌进展中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 恶性黑色素瘤是一种侵袭性皮肤癌,在转移后预后不佳.
- 了解黑色素瘤转移和可塑性的分子驱动因素对于开发有效治疗非常重要.
研究的目的:
- 研究转录因子激活增强剂结合蛋白2ε (AP2ε) 在黑色素瘤转移和可塑性中的作用.
- 确定黑色素瘤患者AP2ε表达水平的临床意义.
主要方法:
- 使用了一种转基因黑色素瘤小鼠模型,AP2ε功能丧失.
- 在AP2ε缺乏的黑色素瘤细胞上进行了体外迁移测定.
- 分析了生物打印3D黑色素瘤模型中的AP2ε活性,这些模型具有不同的细胞表型.
主要成果:
- AP2ε被确定为黑色素瘤转移和可塑性的强有力的激活剂.
- 在黑色素瘤患者中,高AP2ε水平与更差的预后相关.
- AP2ε缺乏在体外显著降低了黑色素瘤细胞迁移和体内转移潜力.
- 与增殖细胞相比,静止和迁移性黑色素瘤细胞中的AP2ε活性更高.
结论:
- AP2ε在维持黑色素瘤细胞可塑性和迁移方面发挥着至关重要的,以前未被认可的作用.
- 准AP2ε可能为抑制黑色素瘤转移提供一种新的治疗策略.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


